Global Ankylosing Spondylitis Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

By Drug;

Cosentyx, Humira, Simponi, Remicade, Enbrel, Cimzia and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).

Report ID: Rn154136516 Published Date: June, 2024 Updated Date: July, 2024

Download Free Sample Now Request Customized Sample

Introduction

Global Ankylosing Spondylitis Market (USD Million), 2020 - 2030

In the year 2023, the Global Ankylosing Spondylitis Market was valued at USD 5,722.46 million. The size of this market is expected to increase to USD 9,618.18 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 7.7%.

Global Ankylosing Spondylitis Market Report Snapshot

Parameters	Description
Market	Global Ankylosing Spondylitis Market
Study Period	2020 - 2030
Base Year (for Ankylosing Spondylitis Market Size Estimates)	2023
Drivers	Revenue Analysis (Historical & Forecast) for all segments and geography Market Share Analysis Drivers, Restraints and Opportunity Analysis Market Opportunity Map PEST Analysis Porter's Five Forces Analysis Company's SWOT Analysis Competitors Product Heat Map Analysis
Restraints	Drug (Cosentyx, Humira, Simponi, Remicade, Enbrel, Cimzia and Others.)
Opportunities	North America Europe Asia Pacific Middle East and Africa Latin America

Segment Analysis

This report extensively covers different segments of Global Ankylosing Spondylitis Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points and, insights that are generated from analysis of these data points (data trends and patterns).

Global Ankylosing Spondylitis Segment Analysis

In this report, the Global Ankylosing Spondylitis Market has been segmented by Drug and Geography.

Global Ankylosing Spondylitis Market, Segmentation by Drug

The Global Ankylosing Spondylitis Market has been segmented by Drug into Cosentyx, Humira, Simponi, Remicade, Enbrel, Cimzia and Others.

Global Ankylosing Spondylitis Market, Segmentation by Geography

In this report, the Global Ankylosing Spondylitis Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Ankylosing Spondylitis Market Share (%), by Geographical Region, 2023

Market Trends

This report provides an in depth analysis of various factors that impact the dynamics of Global Ankylosing Spondylitis Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Competitive Landscape Analysis

Key players in Global Ankylosing Spondylitis Market include:

In this report, the profile of each market player provides following information:

Company Overview and Product Portfolio
Key Developments
Financial Overview
Strategies
Company SWOT Analysis

Introduction
1. Research Objectives and Assumptions
2. Research Methodology
3. Abbreviations
Market Definition & Study Scope
Executive Summary
1. Market Snapshot, By Drug
2. Market Snapshot, By Region
Global Ankylosing Spondylitis Market Dynamics
1. Drivers, Restraints and Opportunities
  1. Drivers
  2. Restraints
  3. Opportunities
2. PEST Analysis
  1. Political Analysis
  2. Economic Analysis
  3. Social Analysis
  4. Technological Analysis
3. Porter's Analysis
  1. Bargaining Power of Suppliers
  2. Bargaining Power of Buyers
  3. Threat of Substitutes
  4. Threat of New Entrants
  5. Competitive Rivalry
Market Segmentation
1. Global Ankylosing Spondylitis Market, By Drug, 2020 - 2030 (USD Million)
  1. Cosentyx
  2. Humira
  3. Simponi
  4. Remicade
  5. Enbrel
  6. Cimzia
  7. Others
2. Global Ankylosing Spondylitis Market, By Geography, 2020 - 2030 (USD Million)
  1. North America
    1. United States
    2. Canada
  2. Europe
    1. Germany
    2. United Kingdom
    3. France
    4. Italy
    5. Spain
    6. Nordic
    7. Benelux
    8. Rest of Europe
  3. Asia Pacific
    1. Japan
    2. China
    3. India
    4. Australia & New Zealand
    5. South Korea
    6. ASEAN (Association of South East Asian Countries)
    7. Rest of Asia Pacific
  4. Middle East & Africa
    1. GCC
    2. Israel
    3. South Africa
    4. Rest of Middle East & Africa
  5. Latin America
    1. Brazil
    2. Mexico
    3. Argentina
    4. Rest of Latin America
Competitive Landscape
1. Company Profiles
Analyst Views
Future Outlook of the Market